SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-23-005038
Filing Date
2023-01-19
Accepted
2023-01-19 16:45:43
Documents
2
Period of Report
2023-01-17

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm233937-7_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm233937-7_4seq1.xml 4 7918
2 EXHIBIT 24 tm233937d7_ex24.htm EX-24 7231
  Complete submission text file 0001104659-23-005038.txt   16516
Mailing Address 230 PARK AVENUE SUITE 3350 NEW YORK NY 10169
Business Address 230 PARK AVENUE SUITE 3350 NEW YORK NY 10169 212-847-9841
Y-mAbs Therapeutics, Inc. (Issuer) CIK: 0001722964 (see all company filings)

IRS No.: 474619612 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address HENRIKSHOJ 8 ROOM 4 VEDBAEK G7 DK-2950
Business Address
Rajah Vignesh (Reporting) CIK: 0001815042 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38650 | Film No.: 23537904